These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8634779)

  • 21. Human papillomavirus infection and p53 protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.
    Engelman DE; Andrade LA; Vassallo J
    Braz J Med Biol Res; 2003 Sep; 36(9):1159-65. PubMed ID: 12937780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of vulvar squamous cell carcinoma in Japanese women.
    Osakabe M; Hayashi M; Katayama Y; Emura I; Nemoto K; Umezu H; Saitoh K; Motoyama T
    Pathol Int; 2007 Jun; 57(6):322-7. PubMed ID: 17539962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPV detection and p53 alteration in squamous cell verrucous malignancies of the lower genital tract.
    Pilotti S; Donghi R; D'Amato L; Giarola M; Longoni A; Della Torre G; De Palo G; Pierotti MA; Rilke F
    Diagn Mol Pathol; 1993 Dec; 2(4):248-56. PubMed ID: 8118602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions.
    Tervahauta AI; Syrjänen SM; Väyrynen M; Saastamoinen J; Syrjänen KJ
    Anticancer Res; 1993; 13(4):1107-11. PubMed ID: 8394670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.
    Rosenthal AN; Hopster D; Ryan A; Jacobs IJ
    Br J Cancer; 2003 Jan; 88(2):251-6. PubMed ID: 12610510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
    Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
    Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
    Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
    Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
    Emanuels AG; Koudstaal J; Burger MP; Hollema H
    Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.
    Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J
    Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
    Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
    Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology.
    Bloss JD; Liao SY; Wilczynski SP; Macri C; Walker J; Peake M; Berman ML
    Hum Pathol; 1991 Jul; 22(7):711-8. PubMed ID: 1649118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways.
    van der Avoort IA; Shirango H; Hoevenaars BM; Grefte JM; de Hullu JA; de Wilde PC; Bulten J; Melchers WJ; Massuger LF
    Int J Gynecol Pathol; 2006 Jan; 25(1):22-9. PubMed ID: 16306780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.
    Al-Ghamdi A; Freedman D; Miller D; Poh C; Rosin M; Zhang L; Gilks CB
    Gynecol Oncol; 2002 Jan; 84(1):94-101. PubMed ID: 11748983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
    Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
    Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression.
    Shindoh M; Chiba I; Yasuda M; Saito T; Funaoka K; Kohgo T; Amemiya A; Sawada Y; Fujinaga K
    Cancer; 1995 Nov; 76(9):1513-21. PubMed ID: 8635051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia.
    Rosenthal AN; Ryan A; Hopster D; Jacobs IJ
    Br J Cancer; 2000 Nov; 83(10):1287-90. PubMed ID: 11044351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.